Challenges in the Treatment of Vasomotor Symptoms:Update in Non-Hormonal Strategies

Abstract

Perimenopause and menopause per se significantly impacts on women quality of life (QoL), especially due to vasomotor symptoms (VMS); their duration is uncertain, and often long. Although menopause hormone therapy (MHT) is the most effective treatment for climacteric symptoms as a whole, its use is contraindicated in some cases. Therefore, it is mandatory that different treatment approaches be offered to women for whom hormone therapy is contraindicated. As for treatment selection, there are a wide range of nonhormonal options, both pharmacological and nonpharmacological. These options include alternative or natural therapies (isoflavones and Cimicifuga Racemosa), lifestyle modifications and complementary therapies. Regarding pharmacological strategies the literature review shows that serotonin-norepinephrine reuptake inhibitors (SNRIs), selective serotonin reuptake inhibitors (SSRIs), antihypertensives and anticonvulsants, decrease the intensity and frequency of VMS, proving a clinically significant improvement. MS-Vasomotor Symptoms; QoL-Quality of Life; MHT-Menopause Hormone Therapy; SNRIs-Serotonin-Norepinephrine Reuptake Inhibitors; SSRIs-Selective Serotonin Reuptake Inhibitors; FMP-Final Menstrual Period; CBT-Cognitive-Behavioral Therapy; GABA-Gamma-Amino Butyric Acid; IMS-International Menopause Society; FDA-Food and Drug Administration; NAMS-North American Menopause Society.

Authors and Affiliations

Belardo Maria Alejandra, Pilnik Susana, Cavanna Malena, De Nardo, Barbara, Starvaggi Agustina, Gelin Marina

Keywords

Related Articles

(Dis)ordered Spaces? Managing the Competing Rights of Children in the Gendered Space of the School Toilet

Rights are often perceived as unproblematic and normative, perhaps particularly in childhood where rights are primarily positioned as protective and participatory. However, in a landscape where t...

Advances in Adenomyosis Diagnosis Utilizing Transvaginal Ultrasonography-A Short Summary

Adenomyosis is a frequent condition, being present in 20% of general gynae population [1,2] and 30-40% of those attending assisted reproductive technology clinics, having a detrimental effect on cases of in vi...

Penis Problems

Doctors will boast that their patients are not shy and tell them everything but that is not how it is. Patients, especially men, are a hindrance to themselves. Erectile dysfunction or the more embarr...

Effectiveness of Textile Materials in Gynaecology and Obstetrics

The article reviews some significant advances in the use of textile materials in obstetrics and gynaecological procedures. Some developments in texture suture materials have been highlighted. Despite millennia of experie...

Preliminary Results with Technical Considerations of Video-Assisted Anal Fistula Treatment (VAAFT)- The First Experience in Bangladesh

Most anorectal fistula represents an epithelised communication path of infectious origin between the rectum or anal canal and the perianal region. The association of endoscopic surgery with the minimally invasive approac...

Download PDF file
  • EP ID EP637845
  • DOI 10.32474/OAJRSD.2018.01.000113
  • Views 88
  • Downloads 0

How To Cite

Belardo Maria Alejandra, Pilnik Susana, Cavanna Malena, De Nardo, Barbara, Starvaggi Agustina, Gelin Marina (2018). Challenges in the Treatment of Vasomotor Symptoms:Update in Non-Hormonal Strategies. Open Access Journal of Reproductive System and Sexual Disorders, 1(3), 76-80. https://europub.co.uk/articles/-A-637845